Doctors at University Hospital Southampton are trialling a new drug, which could be used to treat patients with COVID-19. Developed by Synairgen, a UK-based biotech firm, the drug uses interferon beta, a protein, to fight the virus. Interferon beta is produced when the body is under attack. Chief executive of Synairgen, Richard Marsden, explained that […]